|
|
|
|
|
|
|
|
|
|
|
|
Industry Focus based on practical Experience |
|
|
|
|
|
TAT Capital Partners strategy is based on the industrial expertise of it's team of partners. The practical experience and the
sound understanding of technology and markets as well as the respective
networks define the industries TAT invests in. The focus is on medical
technology with an emphasis on medical devices and micro-/nano technology products. |
|
|
Transatlantic approach with industrial Vision |
|
|
|
|
|
The TAT Team believes in the strength of global niche players in
leading market positions. To achieve a global presence and to overcome the
cultural, political and economical barriers is one of the most challenging
tasks for young companies. TAT with the unique transatlantic team is able to
actively help such companies to expand in the major markets US, Europe and |
|
|
Early-Stage and Established Companies |
|
|
|
|
|
TAT invests in early-stage companies. A key issue to the success of
most early-stage companies is managing the growth and the transatlantic expansion.
The active involvement of TAT Capital Partners targets to help the companies
to overcome such barriers to profitable growth, and to quickly reach a strong
position in the market they are competing. |
|
|
Principal institutional Investor |
|
|
|
|
|
In view of the investment strategy of TAT, in particular its mission
as an industrial partner vis-a-vis the targeted
companies, the Fund must be a principal Venture Capital Investor. This position
allows the Fund to enlarge its influence on both the management guidance and
the control over the financing structure of the companies. |